Conditions: Purulent Bacterial Conjunctivitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 286
Healthy volunteers: no

Brief summary:
Efficacy/Safety of T1225, in comparison to reference product, for the treatment of purulent bacterial conjunctivitis of children.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: T1225 intervention 2: Tobramycin
Intervention descriptions: intervention 1: one drop twice daily (morning and evening) in each eye from Day 0 to Day 2 intervention 2: 1 to 2 drops every two hours while awake on Days 0-1, up to 8×/day, then 1 to 2 drops 4 times daily on Days 2-6

Protocol document: